StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

Zhengye Biotechnology profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -60.0%, against 6.1% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-60.0%−66.0
FY2024Dec 31, 20246.1%−8.8
FY2023Dec 31, 202314.9%−3.1
FY2022Dec 31, 202218.0%–

More Zhengye Biotechnology figures

See a number that looks wrong?